Navigation Links
QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities
Date:6/7/2013

GERMANTOWN, Maryland and HILDEN, Germany, June 7, 2013 /PRNewswire/ --


  • Expansion to about 20 validated gene panels will offer customers new opportunities for targeted clinical sequencing in a growing range of indications in cancer and other diseases
  • Driving adoption through ease of use, quality of results and compatibility with existing NGS workflows as well as with QIAGEN NGS platform now in development
  • Integration of Ingenuity Knowledge Base greatly enhances ease and depth of NGS data interpretation, seen as key bottleneck to NGS adoption in clinical research and diagnostics

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced plans to significantly expand its existing portfolio of molecular assays used in next-generation sequencing (NGS) during 2013 as part of its expansion into this fast-growing market and ambitions to provide an ecosystem of products and services designed to drive greater use of this breakthrough technology in clinical research and diagnostics.

QIAGEN is exhibiting its NGS products at the European Society of Human Genetics Conference from June 8-11 in Paris.

The current portfolio of nine GeneRead™ DNAseq panels launched in late 2012 is being expanded to approximately 20 during the course of 2013. QIAGEN is leveraging its deep molecular content and assay portfolio to create these new gene panels for targeted NGS analysis based on the GeneGlobe portfolio of more than 60,000 annotated molecular assays. Initial customer demand has been very strong for these products, which are "universal" and are designed to be used on any NGS platform, and also to integrate seamlessly into the sample-to-result NGS workflow that includes the QIAGEN GeneRe
'/>"/>

SOURCE Qiagen N.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
2. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
3. QIAGEN Kicks Off Next-Generation Sequencing Initiative With Launch of a Series of Consumable Products to Improve NGS Workflows
4. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
5. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
6. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
7. For Multiple Sclerosis Treatment, Prescriber Base for Genzymes Aubagio Among U.S. Neurologists Has Increased Significantly at Six Months Post-launch, Compared to One and Three Months Post-launch
8. First Large-Scale Population-Based Study in the U.S. Shows Hologics 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection
9. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
10. Isis Publishes Data Demonstrating Antisense Targeting of ApoC-III Significantly Reduces ApoC-III and Triglycerides
11. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... and HOUSTON, TX , Feb. ... "Company") (TSX-V: EPI) and Bloom Burton & Co. Ltd. ... voluntary contractual lock-up (the "Lock-Up") 2,353,130 common shares of ... Shares originally subject to the Lock-Up. Of the Common ... free trading immediately upon release from the Lock-Up while ...
(Date:2/27/2015)... OF PRUSSIA, Pa. , Feb. 27, 2015 /PRNewswire/ ... of its ongoing commitment to the global bleeding disorders ... is donating 2 million international units (IUs) of protein ... is an international not-for- profit organization which has worked ... other inherited bleeding disorders. The donation supports the WFH,s ...
(Date:2/27/2015)... Inc. (NASDAQ: UPI ), a medical device company ... treat voiding dysfunctions, today announced that it will participate ... 10, 2015. Rob Kill , President and CEO, ... present at 4:00 p.m. Pacific Time and meet with ... Ritz Carlton in Laguna Niguel, CA. ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 2CSL Behring Continues Treatment Access Leadership by Donating Bleeding Disorder Protein Therapies IUs to World Federation of Hemophilia 3Uroplasty to Participate in the 27th Annual ROTH Conference 2
... ANGELES , July 29 As of late, ... has been the Lap-Band procedure, a minimally invasive operation in ... a patient,s stomach in order to restrict food capacity and ... results of Lap Band surgery without the use ...
... REYKJAVIK, Iceland , July 29, ... University in the Netherlands today,describe how the impact ... genome (SNP) conferring risk of kidney disease varies with age ... confirmation of,the association made in an earlier study between a ...
Cached Medicine Technology:Sleeve Gastrectomy Procedure With Dr. Michael Feiz Serves as a Highly Effective Alternative to Lap Band Surgery 2Sleeve Gastrectomy Procedure With Dr. Michael Feiz Serves as a Highly Effective Alternative to Lap Band Surgery 3deCODE Shows how Genetic Risk of Kidney Disease Frames Response to Environmental Risk Over Time 2deCODE Shows how Genetic Risk of Kidney Disease Frames Response to Environmental Risk Over Time 3
(Date:2/28/2015)... February 28, 2015 Pioneer Millworks reclaimed ... Japan Architecture & Construction Materials Show, an annual, premier ... than 1,000 suppliers and top manufacturers of the latest ... wood products sourced and manufactured by Pioneer Millworks ... popularity in Japan at restaurants, hotels, retailers, and corporate ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Dr. ... Central Coast area residents, recently announced a special offer ... It’s a treatment option for new and established patients ... 2015 with a bright, white smile, Dr. Patel and ... of $299, marked down from the regular price of ...
(Date:2/28/2015)... York, NY (PRWEB) February 28, 2015 ... discuss federal testosterone lawsuits that have been filed by ... for the second week in March, the Firm notes. ... Court’s website, parties involved in the federal litigation will ... address matters related to prescription therapy treatments designed to ...
(Date:2/28/2015)... Boardman, Ohio (PRWEB) February 28, 2015 ... Bold? Motivational? Supportive? Strategic? , There are all ... unique strengths. To raise awareness of the advantages ... analysis firm PeopleKeys is launching a new product ... help clients better understand the connection between personality ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The noted ... announce that they have officially relaunched their website. The ... user-friendly, but it contains a new section about their ... to read the full biographies of each Friedman Dental ... of the website was designed to provide our patients ...
Breaking Medicine News(10 mins):Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Friedman Dental Group Announces Their Updated Website 2
... Awarded for Medical and Dental Clinic Services, ... Calvin B. Johnson today announced the award of ... Grants to expand access to,primary medical and dental ... are awarded to nonprofit organizations, local governments,and community-based ...
... Conn., Nov. 2 RHEI Pharmaceuticals, Inc., a,fully ... to the China market, will be presenting, at ... Conference on Monday,November 5, 2007 at 2:20 p.m., ... solution for any,company wishing to gain access to ...
... delivery healthcare networks to benefit, MUNDELEIN, ... today,announced that the company has been awarded ... a health care group purchasing,organization, effective October ... Sysmex hematology analyzers,reagents, consumables and services, said ...
... this Cohort of Nucleoside-Naive Chronic Hepatitis B e-Antigen (HBeAg) ... ... BOSTON, Nov. 2 Bristol-Myers Squibb Company,(NYSE: BMY ... showed that 91 percent (98/108) of patients treated with,BARACLUDE(R) (entecavir) ...
... breast cancer,treatment have lead to an increase in the ... small percentage of these women (3% to 5%),will develop ... Your Cancer Today interviews Lee Jones, PhD, from the ... cancer treatments,always outweigh the risks, patients that have gone ...
... preventing blood-stage disease, NEW YORK, Nov. 2 ... today that it has completed its first malaria,prevention ... candidate. The exploratory study was designed to determine ... or a liver-stage,malaria prevention drug. The information obtained ...
Cached Medicine News:Health News:PA Health Department Awards Community Primary Care Challenge Grants 2Health News:Sysmex America Awarded Hematology Contract by Amerinet 2Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 2Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 3Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 4Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 5Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 6Health News:Breast Cancer Survival and Heart Risk, This Week on Your Cancer Today(TM) 2Health News:Immtech Completes Malaria Prevention Trial 2Health News:Immtech Completes Malaria Prevention Trial 3Health News:Immtech Completes Malaria Prevention Trial 4
... premium product for acne, XtremeClear, powered ... on a scalable multi-application platform. A ... acne, XtremeClear works fast, providing noticeable ... treatments. Uncompromising safety in each of ...
... SpaTouch was designed specifically to meet the varying ... is a simple to use, compact, dual application ... lucrative field of light based hair removal. SpaTouch ... is safe for use on nearly all face ...
... all of the benefits and functionality ... the additional feature of being able ... scanner for importing and storage of ... images. This additional feature allows for ...
Inquire...
Medicine Products: